Zydus Lifesciences informs about press release

28 Nov 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated November 28, 2022, titled ‘Zydus receives tentative approval from the USFDA for Levothyroxine Sodium for Injection’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

880.10 -25.90 (-2.86%)
16-Mar-2026 13:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.30
Dr. Reddys Lab 1269.80
Cipla 1294.00
Zydus Lifesciences 880.10
Lupin 2291.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×